1479-5876-5-60-2.jpg (17.36 kB)
Overall survival of patients enrolled in trial compared with historical control
figure
posted on 2011-12-31, 12:08 authored by Howard L Kaufman, Seunghee Kim-Schulze, Kelledy Manson, Gail DeRaffele, Josephine Mitcham, Kang Seok Seo, Dae Won Kim, John MarshallCopyright information:
Taken from "Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer"
http://www.translational-medicine.com/content/5/1/60
Journal of Translational Medicine 2007;5():60-60.
Published online 26 Nov 2007
PMCID:PMC2217514.
Median overall survival = 6.30 months (Trial), and 3.1 months (control).